Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

WIN 2012 /
WINTHER: The WIN therapeutics clinical trial

28th - 29th Jun 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 13.07.12
Views: 8227
Rating:

Prof Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

The WIN Consortium (Worldwide Innovative Networking in personalized cancer medicine), has launched WINTHER, an original academic and international clinical trial.

This is the first clinical trial offering a choice of therapy guided by the biology to the majority of patients included in the study.

From a double biopsy of the tumour (or metastasis) and normal tissue of each patient, a complete biological analysis will be carried out (DNA, RNA and microRNA) with the most advanced technologies . The therapeutic decision will be discussed based on an estimated drug efficacy scoring bioinformatics tool based on these investigations.

The European Community, under the EU FP7  program, has declared WINTHER eligible for a grant, which is currently under negotiation.

This recognition by an independent European jury is a guarantee of the value of the scientific concept and methodology of the project. The aim of this study is to propose a personalized treatment to the vast majority of patients. This strategy represents a breakthrough compared to current oncology practice, which at best offers a personalized biology-guided therapy to 30 % of patients involved in clinical trials.

 

Filming supported by Amgen

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation